Table 5.

Average crude incidence rates by histology.

	Male				Female				Total
	N	%	ASR∗	95% CI	N	%	ASR	95% CI	N	%	ASR	95% CI
Primary tumours	9695	95 .51	5.56	5.41-5.71	6852	95.25	3.93	3.81-4.06	16547	95.40	5.19	4.99-5.38
Diffuse astrocytic and other oligodendroglial tumours	5144	50.68	2.88	2.79-2.98	3244	45.09	1.81	1.74-1.89	8388	48.36	2.40	2.30-2.50
Others	12	0.11	0.007	0-0.01	3	0.042	0.002	0.0001-0.005	15	0.087	0.004	0.002-0.008
Embryonal tumour	474	4.67	0.27	0.23-0.3	315	4.38	0.19	0.16-0.22	789	4.55	0.23	0.20-0.027
Meningioma	160	1.58	0.084	0.06-0.12	217	3.02	0.117	0.084-0.156	377	2.17	0.12	0.12-0.14
Mesenchymal	77	0.759	0.04	0.03-0.05	46	0.639	0.02	0.01-0.03	123	0.709	0.04	0.02-0.05
Melanocytic tumour	11	0.109	0.006	0-0.02	5	0.070	0.003	0.0001-0.015	16	0.092	0.003	0.001-0.006
Lymphomas	268	2.649	0.15	0.13-0.18	205	2.85	0.12	0.10-0.14	473	2.73	0.16	0.12-0.18
Germ cell	24	0.236	0.013	0.01-0.03	20	0.278	0.011	0.003-0.028	44	0.254	0.012	0.005-0.020
Unspecified malignancy	3130	30.83	1.87	1.78-1.95	2475	34.40	1.45	1.39-1.55	5605	32.32	2.03	1.88-2.18
Other astrocytic tumours	32	0.315	0.016	0.01-0.02	27	0.375	0.013	0.006-0.021	59	0.340	0.015	0.008-0.022
Other gliomas	8	0.079	0.005	0-0.01	7	0.097	0.003	0.0001-0.006	15	0.087	0.004	0.001-0.008
Ependymal tumour	335	3.30	0.17	0.14-0.20	273	3.780	0.13	0.11-0.16	608	3.51	0.17	0.14-0.20
Choroid plexus tumour	12	0.118	0.01	0.01-0.02	6	0.083	0.003	0.0001-0.015	18	0.104	0.006	0.001-0.011
Cranial and paraspinal nerve tumours	8	0.079	0.004	0.001-0.007	9	0.125	0.004	0.001-0.008	17	0.098	0.004	0-0.0001
Secondary tumour	375	3.69	0.23	0.20-0.26	286	3.98	0.17	0.14-0.19	661	3.81	0.21	0.18-0.25
Primary or secondary tumours	81	0.798	0.049	0.04-0.06	56	0.779	0.031	0.02-0.04	137	0.790	0.042	0.027-0.057

^∗ASR: age-standardized incidence rate (per 10⁵ inhabitants per year).